These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15047209)

  • 1. Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer.
    Khabele D; Lopez-Jones M; Yang W; Arango D; Gross SJ; Augenlicht LH; Goldberg GL
    Gynecol Oncol; 2004 Apr; 93(1):19-26. PubMed ID: 15047209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells.
    Pellicciotta I; Yang CP; Goldberg GL; Shahabi S
    Gynecol Oncol; 2011 Sep; 122(3):625-31. PubMed ID: 21621254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epothilone B induces human ovarian cancer OV-90 cell apoptosis via external pathway.
    Rogalska A; Marczak A
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):700-12. PubMed ID: 25721485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells.
    Yamaguchi H; Paranawithana SR; Lee MW; Huang Z; Bhalla KN; Wang HG
    Cancer Res; 2002 Jan; 62(2):466-71. PubMed ID: 11809697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
    Chen JG; Yang CP; Cammer M; Horwitz SB
    Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells.
    Shahabi S; Yang CP; Goldberg GL; Horwitz SB
    Gynecol Oncol; 2010 Nov; 119(2):345-50. PubMed ID: 20674962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Toxicol In Vitro; 2014 Jun; 28(4):675-83. PubMed ID: 24583341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of epothilone B-induced cell death in normal ovarian cells.
    Rogalska A; Gajek A; Marczak A
    Cell Biol Int; 2013 Dec; 37(12):1330-9. PubMed ID: 23955989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    Ong PS; Chan SY; Ho PC
    Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
    Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
    Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Phytomedicine; 2019 Aug; 61():152847. PubMed ID: 31029905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.
    Kadra G; Finetti P; Toiron Y; Viens P; Birnbaum D; Borg JP; Bertucci F; Gonçalves A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1035-47. PubMed ID: 21792624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
    Seagle BL; Yang CP; Eng KH; Dandapani M; Odunsi-Akanji O; Goldberg GL; Odunsi K; Horwitz SB; Shahabi S
    Gynecol Oncol; 2015 Jul; 138(1):159-64. PubMed ID: 25958320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
    Roque DM; Bellone S; Buza N; Romani C; Cocco E; Bignotti E; Ravaggi A; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.